Zymeworks signed a deal with Jazz Pharmaceuticals to develop and commercialize Zymeworks’ lead drug candidate, zanidatamab, which targets the cancer… Read More
DexCare, a spinout of Providence’s digital innovation group, has acquired commerce platform Womp Inc., a 12-year old Bellingham, Wash.-based startup.… Read More
Seattle-area health data startup Truveta announced a collaboration Tuesday with Boston Scientific, a leading medical device company. The partnership will… Read More
Seagen has inked a deal to develop, manufacture and commercialize an experimental immuno-oncology agent from Lava Therapeutics, a biotech company… Read More
The National Cancer Institute has awarded Seattle’s Institute for Systems Biology $13 million to lead a collaborative cancer center studying… Read More
Washington Research Foundation has appointed a new CEO: Tom Daniel, former chairman of the University of Washington’s Department of Biology.… Read More